Un fármaco usado en el embarazo en los 1960 y los 1970 podría vincularse con el cáncer de colon
MARTES, 14 de marzo de 2023 (HealthDay News) — Los hijos de las mujeres que tomaron un medicamento común contra las náuseas del embarazo en las décadas de los 1960 y los 1970 quizá tengan un riesgo más alto de cáncer de colon, según un nuevo estudio….
Learn MoreColon Cancer in the Young: One Woman’s Story
WEDNESDAY, March 15, 2023 (HealthDay News) — Tatiana Gonzalez had just quit her job as a postal carrier, and with it the 12 miles a day she walked as she delivered people’s mail.So Gonzalez, then 39, figured that was why she suddenly became so consti…
Learn MoreDrug Used in Pregnancies in 1960s, ’70s May Be Tied to Colon Cancers Today
TUESDAY, March 14, 2023 (HealthDay News) — The children of women who took a common anti-nausea drug for pregnancy in the 1960s and 1970s may be at higher risk of colon cancer, according to a new study.The drug, dicyclomine, is used to treat spasms ca…
Learn MoreEl cáncer de colon se detecta en personas más jóvenes, y en etapas más avanzadas
MIÉRCOLES, 1 de marzo de 2023 (HealthDay News) — El cáncer de colon continúa en aumento entre los adultos más jóvenes de EE. UU., y la Sociedad Americana Contra El Cáncer (American Cancer Society) informa que los casos se han duplicado entre las pers…
Learn MoreCRC Incidence Shifting to Younger Adults, More Advanced Disease
WEDNESDAY, March 1, 2023 (HealthDay News) — The incidence of colorectal cancer (CRC) is shifting to younger individuals and is being diagnosed at more advanced stages, according to a report published online March 1 in CA: A Cancer Journal for Clinici…
Learn MoreColon Cancer Is Being Spotted in Younger People, and at Later Stages
WEDNESDAY, March 1, 2023 (HealthDay News) — Colon cancer continues to rise among younger U.S. adults, with the American Cancer Society reporting a doubling of cases in people younger than 55 in about 25 years.Also, significantly more Americans are be…
Learn MoreAdenoma Detection Rate Inversely Linked to Postcolonoscopy CRC
WEDNESDAY, Feb. 22, 2023 (HealthDay News) — Adenoma detection rate (ADR) is associated with the postcolonoscopy colorectal cancer (PCCRC) rate in a fecal immunochemical test (FIT)-based screening setting, according to a study published online Feb. 21…
Learn MoreDefensive Information Processing Is Barrier to CRC Screening Uptake
TUESDAY, Feb. 7, 2023 (HealthDay News) — Defensive information processing (DIP) is a barrier to colorectal cancer screening uptake, according to a study published online Feb. 6 in Cancer.Nicholas Clarke, Ph.D., from Dublin City University in Ireland,…
Learn More